Intellect Neurosciences Inc

Type: Company

Name: Intellect Neurosciences Inc

First reported May 14 2013 - Updated May 15 2013 - 1 reports

Form NT 10-Q Intellect Neurosciences, For: Mar 31

StreetInsider.com - Form NT 10-Q Intellect Neurosciences, For: Mar 31 ... [Published Street Insider - May 14 2013]

Entities: Intellect Neurosciences Inc, 10-q

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Global Therapeutic Vaccines Market - Industry Analysis, Market Share, Size, Growth, Trends, And Forecast, 2012 - 2018

Therapeutic vaccines function by triggering a body immune response against a disease. The global was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic ... [Published MyNewsDesk - May 14 2013]

Entities: Vaccine, Market, Research & Development, immune response

First reported May 02 2013 - Updated May 03 2013 - 4 reports

Judge Gives Onetime "King of Biotech" 4 Years in Prison

A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities laws. David Blech, 57, pleaded guilty in May 2012 to securities fraud ... [Published BioSpace - May 03 2013]

Entities: Biotechnology, Colleen McMahon, Intellect Neurosciences Inc, Per-Se Technologies Inc

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Bear Stearns Companies Inc

David Blech Gets Four Years for Manipulating Stock Prices

David Blech, who got probation for an investment fraud conviction in 1998, was sentenced to four years in prison today after pleading guilty to manipulating stock prices.“I’m afraid that you had all the mercy that you’re going to get,” U.S. District Judge ... [Published Bloomberg - May 02 2013]

Entities: Bear Stearns Companies Inc, Intellect Neurosciences Inc, Manhattan

First reported Apr 14 2013 - Updated Apr 15 2013 - 2 reports

Pink Sheet's Movers to Watch - Intellect Neurosciences, Inc (PINK:ILNS), Evolucia Inc, Ic Punch Media Inc, Friendly Energy Exploration

StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.New York, NY -- (SBWIRE) -- 04/15/2013 -- StockRunway.com ... [Published SBWire - Apr 15 2013]

Entities: Friendly Energy Exploration, Intellect Neurosciences Inc, oxidative stress, Day Trading

First reported Apr 12 2013 - Updated Apr 12 2013 - 1 reports

Eye Catching Pink Sheet's Stocks - DRAKE GOLD RESOURCES (PINK:DKGR), W Technologies Inc, HyperSolar Inc, Intellect Neurosciences, Inc

Birmingham, West Midlands -- (SBWIRE) -- 04/12/2013 -- Value Penny Stocks issues special report on DRAKE GOLD RESOURCES (PINK:DKGR), W Technologies Inc (PINK:WTCG), HyperSolar Inc (PINK:HYSR), Intellect Neurosciences, Inc (PINK:ILNS)DRAKE GOLD RESOURCES(PINK:DKGR) ... [Published SBWire - Apr 12 2013]

Entities: HyperSolar Inc, W Technologies Inc, DRAKE GOLD RESOURCES INC, Intellect Neurosciences Inc

First reported Mar 08 2013 - Updated Mar 08 2013 - 1 reports

SEC charges California lawyer over easy opinion letters

The companies that Mr. Reiss allegedly serviced included Primegen Energy Corp., a Vancouver-linked pink sheets promotion that included William Scott Marshall on its board. The SEC says that Mr. Reiss helped Primegen issue 20.5 million shares that the ... [Published Stockwatch - Mar 08 2013]

Entities: Intellect Neurosciences Inc, Securities Fraud, PrimeGen Energy Corp

Quotes

"I am ashamed to again be before a court pleading for its mercy" Blech said

U.S. judge gives onetime 'King of Biotech' four years in prison [Published Tutorial Finder - May 03 2013]

...The exchange wrote him a letter that month stating that it would no longer accept his opinions. The letter said that reviews of his work "strongly suggest that you did not perform the legal work necessary to support the assertions made in such opinions." Mr. Reiss, however, continued to write letters even after the ban, the SEC claims

SEC charges California lawyer over easy opinion letters [Published Stockwatch - Mar 08 2013]

...important Alzheimer's research is dependent on receiving such payments from its licensees," said Daniel Chain, chairman and CEO of Intellect. "After exhausting all non-litigious options to secure our $2 million milestone payment, we realized we have no option save pursuing payment via the courts."

Intellect sues pharma licensee for non payment of $2 mn milestone [Published PharmaBiz - Oct 17 2012]

"IN-N01 is an important addition to Intellect's diversified preclinical pipeline," commented Daniel G Chain, PhD, Intellect's chairman and CEO. "The recent phase III data for bapineuzumab, an IgG1 antibody, despite failing to show improvement in clinical endpoints, demonstrated through the use of biomarkers the drug engaged the amyloid beta target and reduced neurodegeneration indicating both the need for earlier intervention and improved antibody-based therapies. We anticipate IN-N01 will have improved safety, which means that it can be used at higher, more frequent doses that likely will result in clinical efficacy, especially if administered to presymptomatic patients."

Intellect Neurosciences, MRCT complete humanization of 82E1, a next-generation monoclonal antibod ... [Published PharmaBiz - Sep 21 2012]

More Content

sort by: Date \| Relevance
Form NT 10-Q Intellect Neurosciences, For: Mar 31 [Published Street Insider - May 14 2013]
Global Therapeutic Vaccines Market - Industry ... [Published MyNewsDesk - May 14 2013]
New Study: World Therapeutic Vaccines Market - ... [Published MyNewsDesk - May 14 2013]
Judge Gives Onetime "King of Biotech" 4 Years i... [Published BioSpace - May 03 2013]
Investor Sentenced in Manhattan Federal Court t... [Published 7thSpace - May 03 2013]
U.S. judge gives onetime 'King of Biotech' four... [Published Tutorial Finder - May 03 2013]
Angry federal judge gives NY biotech financier ... [Published Washington Post - May 03 2013]
CORRECTED-US judge gives onetime 'King of Biote... [Published CNBC - May 02 2013]
U.S. judge gives onetime 'King of Biotech' four... [Published Hampton Roads Daily Press - May 02 2013]
David Blech Gets Four Years for Manipulating St... [Published Bloomberg - May 02 2013]
Pink Sheet's Movers to Watch - Intellect Neuros... [Published SBWire - Apr 15 2013]
Pink Sheet's Alert - Intellect Neurosciences, I... [Published SBWire - Apr 14 2013]
Eye Catching Pink Sheet's Stocks - DRAKE GOLD R... [Published SBWire - Apr 12 2013]
Intellect Neurosciences Issues Letter to Shareh... [Published GlobeNewswire: Advertising News - Mar 29 2013]
SEC charges California lawyer over easy opinion... [Published Stockwatch - Mar 08 2013]
Intellect Neurosciences to Present at Bio-Europ... [Published GlobeNewswire: Advertising News - Feb 28 2013]
Intellect Neurosciences Issues Letter to Shareh... [Published GlobeNewswire: Acquisitions News - Feb 13 2013]
Intellect Neurosciences Initiates in vivo Proof... [Published GlobeNewswire: Acquisitions News - Feb 07 2013]
Intellect Neurosciences CEO Daniel Chain Provid... [Published GlobeNewswire: Acquisitions News - Jan 02 2013]
Intellect Neurosciences CEO Daniel Chain to Dis... [Published GlobeNewswire: Advertising News - Dec 06 2012]
Intellect Neurosciences Announces New Findings ... [Published GlobeNewswire: Advertising News - Nov 28 2012]
Intellect sues pharma licensee for non payment ... [Published PharmaBiz - Oct 17 2012]
8-K - Intellect Neurosciences, Inc. (0001337905... [Published SEC Filings - Oct 12 2012]
Intellect Neurosciences, MRCT complete humaniza... [Published PharmaBiz - Sep 21 2012]